Latest filing published 16 May 2025 for Lantheus Holdings, Inc..
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Gary J. Pruden has 31 filings between June 9, 2016 and May 16, 2025, across three companies: Lantheus Holdings, Inc. (15, as a Director), Motus GI Holdings, Inc. (9, as a Director) and Johnson & Johnson (7, as Exec VP, WW Chair, Med Devices). None falls in the last 12 months.
Four sales total EUR 4.0 million, with a median of EUR 1,046,883. The largest are from February 28, 2017 (EUR 1,881,948) at Johnson & Johnson, and from July 10, 2024 (EUR 1,099,251) at Lantheus Holdings, Inc. The 2 purchases, both at Motus GI Holdings, Inc. (February 16, 2018 and July 1, 2019), involve token amounts, a few euros only, and make up 33% of market trades. The rest of the record is 20 grants and 2 option exercises.
The yearly count runs from 1 in 2016 and 2023 to 6 in 2017 and 2020. At Motus GI Holdings, Inc., 2 of Pruden's trades fall within 30 days of a trade by each of David P. Hochman, Gary E. Jacobs, Mark Pomeranz or Perceptive Advisors LLC, all in the same direction.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 31 declarations